Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2012, Article ID 931902, 12 pages
http://dx.doi.org/10.1155/2012/931902
Clinical Study

Bilateral Transplantation of Allogenic Adult Human Bone Marrow-Derived Mesenchymal Stem Cells into the Subventricular Zone of Parkinson’s Disease: A Pilot Clinical Study

1Advanced Neuro Science Institute, BGS Global Hospital, Bangalore 560060, India
2ANSA Research Foundation, Indiranagar, Bangalore 560038, India

Received 31 August 2011; Accepted 1 November 2011

Academic Editor: Francesco Dazzi

Copyright © 2012 N. K. Venkataramana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [45 citations]

The following is the list of published articles that have cited the current article.

  • Sonia Martínez-Herrero, Ignacio M. Larráyoz, Laura Ochoa-Callejero, Josune García-Sanmartín, and Alfredo Martínez, “Adrenomedullin as a Growth and Cell Fate Regulatory Factor for Adult Neural Stem Cells,” Stem Cells International, vol. 2012, pp. 1–18, 2012. View at Publisher · View at Google Scholar
  • Johannes P.J.M. de Munter, Chongsik Lee, and Erik C. Wolters, “Cell based therapy in Parkinsonism,” Translational Neurodegeneration, vol. 2, no. 1, 2013. View at Publisher · View at Google Scholar
  • Lin Song, Peng Liu, Chao Han, Yang Liu, Wei Zou, Hua Piao, Yachen Wang, and Jing Liu, “A novel approach to facilitate dopaminergic neuron generation from stem-cells: The combination of genetic modification and signaling factors within a three-dimensional perfusion microbioreactor,” Medical Hypotheses, vol. 80, no. 4, pp. 407–410, 2013. View at Publisher · View at Google Scholar
  • Virginie Neirinckx, Cecile Coste, Bernard Rogister, and Sabine Wislet-Gendebien, “Concise Review: Adult Mesenchymal Stem Cells, Adult Neural Crest Stem Cells, and Therapy of Neurological Pathologies: A State of Play,” Stem Cells Translational Medicine, vol. 2, no. 4, pp. 284–296, 2013. View at Publisher · View at Google Scholar
  • Wenyu Fu, Zhijuan Zheng, Wenxin Zhuang, Dandan Chen, Xiaocui Wang, Xihe Sun, and Xin Wang, “Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy,” International Journal of Neuroscience, vol. 123, no. 12, pp. 883–891, 2013. View at Publisher · View at Google Scholar
  • Gesine Paul, and Sergey V. Anisimov, “The secretome of mesenchymal stem cells: Potential implications for neuroregeneration,” Biochimie, vol. 95, no. 12, pp. 2246–2256, 2013. View at Publisher · View at Google Scholar
  • Deirdre B. Hoban, Ben Newland, Teresa C. Moloney, Linda Howard, Abhay Pandit, and Eilis Dowd, “The reduction in immunogenicity of neurotrophin overexpressing stem cells after intra-striatal transplantation by encapsulation in an in situ gelling collagen hydrogel,” Biomaterials, vol. 34, no. 37, pp. 9420–9429, 2013. View at Publisher · View at Google Scholar
  • Xingmei Feng, Jing Xing, Guijuan Feng, Aimin Sang, Biyu Shen, Yue Xu, Jinxia Jiang, Suzhe Liu, Wei Tan, Zhifeng Gu, and Liren Li, “Age-Dependent Impaired Neurogenic Differentiation Capacity of Dental Stem Cell is Associated with Wnt/beta-Catenin Signaling,” Cellular and Molecular Neurobiology, vol. 33, no. 8, pp. 1023–1031, 2013. View at Publisher · View at Google Scholar
  • Matthew B. Murphy, Kathryn Moncivais, and Arnold I. Caplan, “Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine,” Experimental and Molecular Medicine, vol. 45, 2013. View at Publisher · View at Google Scholar
  • Patrick Hickey, and Mark Stacy, “AAV2-neurturin (CERE-120) for Parkinson's disease,” Expert Opinion on Biological Therapy, vol. 13, no. 1, pp. 137–145, 2013. View at Publisher · View at Google Scholar
  • Virginie Neirinckx, Alice Marquet, Bernard Rogister, Cecile Coste, and Sabine Wislet-Gendebien, “Adult Bone Marrow Neural Crest Stem Cells and Mesenchymal Stem Cells Are Not Able to Replace Lost Neurons in Acute MPTP-Lesioned Mice,” Plos One, vol. 8, no. 5, 2013. View at Publisher · View at Google Scholar
  • Ming Li, and Susumu Ikehara, “Bone-marrow-derived mesenchymal stem cells for organ repair,” Stem Cells International, 2013. View at Publisher · View at Google Scholar
  • Diego Albani, Antonio Gloria, Carmen Giordano, Serena Rodilossi, Teresa Russo, Ugo D'Amora, Marta Tunesi, Alberto Cigada, Luigi Ambrosio, and Gianluigi Forloni, “Hydrogel-Based Nanocomposites and Mesenchymal Stem Cells: A Promising Synergistic Strategy for Neurodegenerative Disorders Therapy,” Scientific World Journal, 2013. View at Publisher · View at Google Scholar
  • Haitao Xi, Lin Chen, Hongyun Huang, Feng Zhang, Yancheng Liu, Di Chen, and Juan Xiao, “Preliminary report of multiple cell therapy for patients with multiple system atrophy,” Cell Transplantation, vol. 22, no. 1, pp. S93–S99, 2013. View at Publisher · View at Google Scholar
  • Sergey V Anisimov, and Gesine Paul, “Transplantation of mesenchymal stem cells: a future therapy for Parkinson’s disease?,” Future Neurology, vol. 9, no. 4, pp. 475–486, 2014. View at Publisher · View at Google Scholar
  • Aruna V. Vanikar, Hargovind L. Trivedi, Ashutosh Kumar, Saroj Chooramani Gopal, and Vivek B. Kute, “Mesenchymal stem cells and transplant tolerance,” Nephrology, 2014. View at Publisher · View at Google Scholar
  • Björn Brändl, Susanne A. Schneider, Jeanne F. Loring, John Hardy, Philip Gribbon, and Franz-Josef Müller, “Stem cell reprogramming: Basic implications and future perspective for movement disorders,” Movement Disorders, 2014. View at Publisher · View at Google Scholar
  • Marta Garcia-Contreras, Cesar David Vera-Donoso, Jose Miguel Hernandez-Andreu, Jose Manuel Garcia-Verdugo, and Elisa Oltra, “Therapeutic Potential of Human Adipose-Derived Stem Cells (ADSCs) from Cancer Patients: A Pilot Study,” Plos One, vol. 9, no. 11, 2014. View at Publisher · View at Google Scholar
  • Sergey V Anisimov, “Stem cell therapy for neurodegenerative diseases: mind the gap,” Future Neurology, vol. 9, no. 1, pp. 9–12, 2014. View at Publisher · View at Google Scholar
  • Hideki Mochizuki, Chi-Jing Choong, and Toru Yasuda, “The promises of stem cells: Stem cell therapy for movement disorders,” Parkinsonism and Related Disorders, vol. 20, no. 1, pp. S128–S131, 2014. View at Publisher · View at Google Scholar
  • Johannes P.J.M. de Munter, Eldad Melamed, and Erik Ch. Wolters, “Stem cell grafting in parkinsonism – Why, how and when,” Parkinsonism & Related Disorders, vol. 20, pp. S150–S153, 2014. View at Publisher · View at Google Scholar
  • Katarzyna Skowron, Marcin Tomsia, and Piotr Czekaj, “An Experimental Approach to the Generation of Human Embryonic Stem Cells Equivalents,” Molecular Biotechnology, vol. 56, no. 1, pp. 12–37, 2014. View at Publisher · View at Google Scholar
  • Robert Wyse, Gary Dunbar, and Julien Rossignol, “Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases,” International Journal of Molecular Sciences, vol. 15, no. 2, pp. 1719–1745, 2014. View at Publisher · View at Google Scholar
  • Silvia Cerri, Rosaria Greco, Giovanna Levandis, Cristina Ghezzi, Antonina Stefania Mangione, Marie-Therese Fuzzati-Armentero, Arianna Bonizzi, Maria Antonietta Avanzini, Rita Maccario, and Fabio Blandini, “Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behav,” Stem Cells Translational Medicine, vol. 4, no. 9, pp. 1073–1085, 2015. View at Publisher · View at Google Scholar
  • Jing Xing, Min Lian, Qijie Shen, Guijuan Feng, Dan Huang, Xiaohui Lu, Zhifeng Gu, Liren Li, Jinglong Zhang, Shen Huang, Qingsheng You, Xiang Wu, Dongmei Zhang, and Xingmei Feng, “AGS3 is involved in TNF-α medicated osteogenic differentiation of human dental pulp stem cells,” Differentiation, 2015. View at Publisher · View at Google Scholar
  • Jenny Riecke, Katherine M. Johns, Chunyan Cai, Farhaan Shaheer Vahidy, Kaushik Parsha, Erin Furr-Stimming, Mya Schiess, and Sean I. Savitz, “A Meta-Analysis of Mesenchymal Stem Cells in Animal Models of Parkinson's Disease,” Stem Cells and Development, pp. 150702060410005, 2015. View at Publisher · View at Google Scholar
  • Marcello Villanova, and John Robert Bach, “Allogeneic Mesenchymal Stem Cell Therapy Outcomes for Three Patients with Spinal Muscular Atrophy Type 1,” American Journal Of Physical Medicine & Rehabilitation, vol. 94, no. 5, pp. 410–415, 2015. View at Publisher · View at Google Scholar
  • Linda Ottoboni, Donatella De Feo, Arianna Merlini, and Gianvito Martino, “Commonalities in immune modulation between mesemchymal stem cells (MSCs) and neural stem/precursor cells (NPCs),” Immunology Letters, 2015. View at Publisher · View at Google Scholar
  • Reena Haobam, Debasmita Tripathy, Navneet A. Kaidery, and Kochupurackal P. Mohanakumar, “Embryonic Stem Cells Derived Neuron Transplantation Recovery in Models of Parkinsonism in Relation to Severity of the Disorder in Rats,” Rejuvenation Research, vol. 18, no. 2, pp. 173–184, 2015. View at Publisher · View at Google Scholar
  • Wen-Yu Fu, Feng-Jie Li, Jin-Cheng Liu, Xiao-Xiao Wang, Wen-Xin Zhuang, and Qian Wang, “Lentiviral vector mediated Nurrl gene-modified mesenchymal stem cells for the treatment of Parkinson's disease rat model,” Acta Anatomica Sinica, vol. 46, no. 6, pp. 742–749, 2015. View at Publisher · View at Google Scholar
  • Dandan Chen, Wenyu Fu, Wenxin Zhuang, Cui Lv, Fengjie Li, and Xin Wang, “Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease,” Journal of Neuroscience Research, 2016. View at Publisher · View at Google Scholar
  • Mariano García-Arranz, Maria Dolores Herreros, Carolina González-Gómez, Paloma de la Quintana, Héctor Guadalajara, Tihomir Georgiev-Hristov, Jacobo Trébol, and Damián Garcia-Olmo, “Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial,” STEM CELLS Translational Medicine, vol. 5, no. 11, pp. 1441–1446, 2016. View at Publisher · View at Google Scholar
  • Wassim Altarche-Xifro, Umberto di Vicino, Maria Isabel Muñoz-Martin, Analía Bortolozzi, Jordi Bové, Miquel Vila, and Maria Pia Cosma, “Functional rescue of dopaminergic neuron loss in Parkinson's disease mice after transplantation of hematopoietic stem and progenitor cells,” EBioMedicine, 2016. View at Publisher · View at Google Scholar
  • Subrata Pramanik, Yanuar Alan Sulistio, and Klaus Heese, “Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy,” Molecular Neurobiology, 2016. View at Publisher · View at Google Scholar
  • Mooi Tiong Liau, Farahnaz Amini, and Thamil Selvee Ramasamy, “The therapeutic potential of stem cells and progenitor cells for the treatment of Parkinson’s disease,” Tissue Engineering and Regenerative Medicine, vol. 13, no. 5, pp. 455–464, 2016. View at Publisher · View at Google Scholar
  • Pietro Gentile, Maria Giovanna Scioli, Alessandra Bielli, Augusto Orlandi, and Valerio Cervelli, “Concise Review: The Use of Adipose-Derived Stromal Vascular Fraction Cells and Platelet Rich Plasma in Regenerative Plastic Surgery,” Stem Cells, 2016. View at Publisher · View at Google Scholar
  • Il-Kwon Kim, Sun-Hyun Kim, Seong-Mi Choi, Byung-Soo Youn, and Han-Soo Kim, “Extracellular Vesicles as Drug Delivery Vehicles for Rheumatoid Arthritis,” Current Stem Cell Research & Therapy, vol. 11, no. 4, pp. 329–342, 2016. View at Publisher · View at Google Scholar
  • Li Jinfeng, Wang Yunliang, Liu Xinshan, Wang Shanshan, Xu Chunyang, Xue Peng, Yang Xiaopeng, Xu Zhixiu, Yin Honglei, Cao Xia, Duan Haifeng, and Cao Bingzhen, “The Effect of MSCs Derived from the Human Umbilical Cord Transduced by Fibroblast Growth Factor-20 on Parkinson’s Disease,” Stem Cells International, vol. 2016, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Dimitrios Kouroupis, Xiao Nong Wang, Yasser El-Sherbiny, Dennis McGonagle, and Elena Jones, “The Safety of Non-Expanded Multipotential Stromal Cell Therapies,” Safety, Ethics and Regulations, pp. 91–118, 2017. View at Publisher · View at Google Scholar
  • Napoleon Torres, Jenny Molet, Cecile Moro, John Mitrofanis, and Alim Benabid, “Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data,” International Journal of Molecular Sciences, vol. 18, no. 10, pp. 2190, 2017. View at Publisher · View at Google Scholar
  • A. Kirkeby, M. Parmar, and R.A. Barker, “Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD),” 2017. View at Publisher · View at Google Scholar
  • Katari Venkatesh, and Dwaipayan Sen, “Mesenchymal stem cells as a source of dopaminergic neurons: A potential cell based therapy for Parkinson’s disease,” Current Stem Cell Research and Therapy, vol. 12, no. 8, pp. 326–347, 2017. View at Publisher · View at Google Scholar
  • Da Yeon Lee, Moon Suk Jin, Balachandran Manavalan, Hak Kyun Kim, Jun Hyeok Song, Tae Hwan Shin, and Gwang Lee, “ Bidirectional Transcriptome Analysis of Rat Bone Marrow-Derived Mesenchymal Stem Cells and Activated Microglia in an In Vitro Coculture System ,” Stem Cells International, vol. 2018, pp. 1–11, 2018. View at Publisher · View at Google Scholar
  • Daniel Mendes Filho, Patrícia d.C. Ribeiro, Lucas F. Oliveira, Diógenes R.M. de Paula, Vanessa Capuano, Thaís S.F. de Assunção, and Valdo J.D. da Silva, “Therapy With Mesenchymal Stem Cells in Parkinson Disease,” The Neurologist, vol. 23, no. 4, pp. 141–147, 2018. View at Publisher · View at Google Scholar
  • Chang-Geng Song, Yi-Zhe Zhang, Hai-Ning Wu, Xiu-Li Cao, Chen-Jun Guo, Yong-Qiang Li, Min-Hua Zheng, and Hua Han, “Stem cells: a promising candidate to treat neurological disorders,” Neural Regeneration Research, vol. 13, no. 7, pp. 1294, 2018. View at Publisher · View at Google Scholar